Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2020-04-16 Regulatory Filings
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1364 characters) and begins with 'RNS Number : 9406J', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' for a security, which is a specific operational notice related to trading mechanisms, not a comprehensive financial report, management change, or shareholder vote result. Since it is a general regulatory announcement that doesn't fit the specific categories like DIV, ER, or DIRS, the most appropriate fallback category is Regulatory Filings (RNS).
2020-04-16 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document begins with an 'RNS Number' and is dated April 15, 2020. The core content announces a 'PDMR Dealing' (Person Discharging Managerial Responsibilities Dealing) involving a Non-Executive Director purchasing shares. This type of insider transaction notification, especially when filed via RNS (Regulatory News Service), directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content is about insider trades, making DIRS the most precise classification over the general RNS fallback.
2020-04-15 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document begins with an 'RNS Number' and is dated April 14, 2020. The content explicitly details a 'PDMR Dealing' (Persons Discharging Managerial Responsibilities) transaction, specifically an acquisition of Ordinary Shares by a Non-Executive Director's controlled fund. This type of insider transaction reporting, especially when referencing EU Market Abuse Regulation and providing specific details of the director, price, and volume, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific subject matter is DIRS, which takes precedence over the general RNS category.
2020-04-14 English
PDMR Dealing
Director's Dealing Classification · 100% confidence The document begins with an 'RNS Number' and is dated April 8, 2020. The content explicitly details a 'PDMR Dealing' (Persons Discharging Managerial Responsibilities) transaction where a Non-Executive Director's controlled fund purchased ordinary shares. This structure, including the detailed tables conforming to EU Market Abuse Regulation requirements for insider transactions, strongly indicates a regulatory filing concerning insider trading or director dealings. Comparing this to the definitions, 'Director's Dealing (Code: DIRS)' is the most specific match. Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2020-04-08 English
PDMR Dealing - Replacement
Director's Dealing Classification · 98% confidence The document is identified by the RNS Number (5768I) and explicitly mentions 'PDMR Dealing' and 'Director/PDMR Shareholding' announcement. It details the acquisition of Ordinary Shares by a Non-Executive Director (Stephen Diggle) through controlled funds. This directly corresponds to the definition of Director's Dealing (insider trades). The presence of the RNS header and the nature of the content confirm it is a regulatory disclosure related to insider transactions, fitting the 'DIRS' code. Although it is an RNS announcement, the specific content points strongly to DIRS over the general RNS fallback.
2020-04-02 English
PDMR Dealing / Grant of Share Options
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'PDMR Dealing / Grant of Share Options' involving a Director (Jon Burrows) and provides specific transaction details required under EU Market Abuse Regulation. This type of insider transaction disclosure is a specific regulatory filing. While it involves director dealings (DIRS), the primary context and distribution method (RNS) strongly suggest it falls under the general regulatory announcement category, especially since DIRS is often for the formal transaction report, whereas this is the public announcement via the exchange's service. However, the core subject matter is the transaction by a Director/PDMR. Given the options, 'Director's Dealing (DIRS)' is the most specific classification for the content (grant of options to a Director), even though it is distributed via RNS. If DIRS was not available, RNS would be the fallback. Since DIRS is available and the content is explicitly about PDMR dealing, DIRS is the best fit.
2020-03-31 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.